Trial intelligence / Profile preview

Scopoderm patch for prevention of postoperative nausea and vomiting after gynecologic laparoscopy

2005-005928-13Phase 3Completed

Sponsor
Landspitali
Start
Jan 2006
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing Scopoderm patch with Placebo patch (2 arms). Primary endpoints: Postoperative nausea severity, Postoperative vomiting severity and 3 more. Started Jan 2006; status: completed.

02

Drugs

scopolamine
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on 2005-005928-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-005928-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call